• xxx

BASU, Dr Bristi

Dr Bristi Basu is an academic consultant in medical oncology, specialising in experimental cancer therapeutics in the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. She trained in Medicine at Oxford University (Prosser Exhibition scholarships) before undertaking clinical speciality training in Medical Oncology at Cambridge. During this time, she completed a PhD in cancer cell biology and drug discovery at the University of Cambridge as the Cancer Research UK Gordon Hamilton-Fairley Clinical Research Training Fellow. She now co-leads the Cambridge Experimental Cancer Medicine Centre with Prof Duncan Jodrell and the CRUK Cambridge Centre Pancreatic Cancer Programme with Dr Giulia Biffi. Other roles include Capacity Building leadership team within the Cambridge NIHR Biomedical Research Centre; NCRI Upper GI Hepatobiliary and Pancreatic Cancer subgroups; Cancer Research UK Clinical Research Committee member; Eastern Lead for NIHR CRN Early Phase Cancer Studies Specialty Group. Her research focus is in drug development and she translates preclinical findings on lead candidate agents into early phase clinical trials of novel therapeutic drugs as chief investigator, principal investigator and co-investigator in academic-led and industry-sponsored Phase I, II and III clinical trials, including first-in-human and first-in-class studies. Her tumour site-specific focus is in hepato-pancreatico-biliary cancers, for which she designs novel clinical trials based on preclinical research that has been performed at the Cambridge

UK Oncology Forum 2024

The UK Oncology Forum is only open to UK healthcare professionals. By choosing to continue to enter the UK Oncology Forum website, you are confirming that you are a UK healthcare professional.